Changeflow GovPing Pharma & Drug Safety Medtronic SynchroMed Implantable Pump Software ...
Priority review Notice Added Final

Medtronic SynchroMed Implantable Pump Software Safety Alert for Health Establishments

Favicon for ansm.sante.fr ANSM Drug & Device Safety Alerts
Detected
Email

Summary

ANSM has published a safety alert (Ref. R2610621) informing French healthcare establishments of a safety action taken by Medtronic Inc. regarding SynchroMed implantable pumps and associated software for the clinical programming tablet. Users have received a letter dated 16/04/2026 with details of the safety concern and recommended actions.

What changed

ANSM has issued an information notice (Ref. R2610621) regarding a safety action implemented by Medtronic Inc. concerning SynchroMed implantable pumps and their associated programming tablet software/accessories. The safety action was communicated directly to affected users via letter dated 16/04/2026, which is attached to the ANSM notice.

Healthcare establishments using Medtronic SynchroMed pumps should immediately review the Medtronic correspondence to identify affected patients, assess any clinical implications, and implement recommended corrective actions. Medical device manufacturers should monitor for related regulatory scrutiny following this safety communication. Clinical staff should verify whether their facility's pump inventory includes affected SynchroMed models and follow any updated protocols issued by Medtronic.

What to do next

  1. Consult the Medtronic Inc. letter for specific safety instructions

Archived snapshot

Apr 16, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

!share
Information n° R2610621 destinée aux établissements de santé L'ANSM a été informée de la mise en œuvre d’une action de sécurité effectuée par la société Medtronic Inc.
Les utilisateurs concernés ont reçu le courrier ci-joint.

Cette action de sécurité est enregistrée à l’ANSM sous le n° R2610621.
Pour toute question, merci de vous adresser directement à l’émetteur de l’action de sécurité. Consultez le courrier de la société Medtronic Inc. (16/04/2026)

Get daily alerts for ANSM Drug & Device Safety Alerts

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from ANSM.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
ANSM
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Substantive
Document ID
R2610621

Who this affects

Applies to
Healthcare providers Medical device makers
Industry sector
3345 Medical Device Manufacturing
Activity scope
Medical device software Implantable pump safety Clinical device use
Geographic scope
France FR

Taxonomy

Primary area
Medical Devices
Operational domain
Clinical Operations
Compliance frameworks
GxP
Topics
Public Health Healthcare

Get alerts for this source

We'll email you when ANSM Drug & Device Safety Alerts publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!